This grant funds research to develop and optimize new devices for brain and addiction disorders, supporting their progress toward readiness for initial human trials.
NIH plans a milestone-driven award supporting planning and early to definitive clinical trials across biomedical and other interventions for up to 7 years; applications are not yet being accepted.
Funding for early-stage trials testing drugs or devices for mental disorder treatment, focusing on clinical effects and underlying mechanisms.
Funding for early testing of new drug or device treatments for mental disorders to understand mechanisms and assess clinical effects.
Funding support available to study and prove effectiveness of potential neurotherapeutic agents for neurological disorders towards further development.